Pharmacy Times interviewed Norman Lepor, MD, a Los Angeles-based cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), on the burden of atherosclerotic cardiovascular disease (ASCVD) and low-density lipoprotein cholesterol management. During the interview, Lepor discussed the burden of ASCVD in the country today.
Assessing The Burden Of Atherosclerotic Cardiovascular Disease In The US
By Pharmacy Times
|June 12, 2023
|pharmacytimes.com
Share